RBC Raises Price Target on Pacira Biosciences to $18 From $16, Keeps Sector Perform Rating

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.44 USD | -4.11% |
|
-2.53% | +35.03% |
Jan. 31 | North American Morning Briefing : Investors in -2- | DJ |
Jan. 30 | Pacira BioSciences, Inc. Announces Board and Audit Committee Changes | CI |